Page last updated: 2024-09-03

u 99194a and Anochlesia

u 99194a has been researched along with Anochlesia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andatsu, S; Kizu, T; Miyoshi, S; Ohno, Y; Sato, M; Shimizu, S; Sugiuchi, T; Tatara, A1
Audinot, V; Bervoets, K; Brocco, M; Dekeyne, A; Desposte, I; Gluck, L; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Rivet, JM1

Other Studies

2 other study(ies) available for u 99194a and Anochlesia

ArticleYear
Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2014, Apr-03, Volume: 50

    Topics: Animals; Catalepsy; Cerebellum; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Indans; Male; Microinjections; Nucleus Accumbens; Piperazines; Pyridines; Rats; Receptors, Dopamine D3; Tetrahydronaphthalenes

2014
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

    Topics: 2-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Biphenyl Compounds; Body Temperature; Catalepsy; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Furans; Humans; Indans; Naphthalenes; Oxazines; Piperazines; Prolactin; Pyrrolidines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3

1998